BioSpace News Archive

XORTX Therapeutics Inc. is pleased to advise that further to its press release of April 6, 2021 that announced the intention of grant, the Company has now received receipt of the patent grant “EPO National Stage of PCT International Application for Compositions and Methods for Treatment and Prevention of Hyperuricemia Related Health Consequences” by the European Patent Office.

Intelivation Technologies announced today that they have achieved FDA 510(k) Clearance of the Golden Isles Pedicle Screw System™ .

Evogene Ltd. announced today that Ofer Haviv , Evogene’s President and CEO, will present at the H.C. Wainwright 23rd Annual Global Investment Conference, 2021, taking place from September 9-15, 2021.

Sutro Biopharma, Inc. today announced that Bill Newell , Chief Executive Officer, will participate in the 2021 Wells Fargo Securities Healthcare Conference during a virtual fireside chat on Thursday, September 9, at 3:20 p.m. ET / 12:20 p.m. PT.

Bicycle Therapeutics plc today announced that management will participate in the following investor conferences in September: Goldman Sachs Eleventh Annual Biotech Symposium on Tuesday, September 7, 2021

Asher Biotherapeutics today announced the closing of an oversubscribed Series B financing, which raised $108 million.

IMV Inc. today announced that members of IMV’s executive management team will be presenting at three investor conferences in September. 2021 Virtual Wells Fargo Healthcare Conference Fireside chat, Thursday, September 9, 2021

Ribon Therapeutics today announced the promotions of Heike Keilhack, Ph.D., to Chief Scientific Officer and Kevin Kuntz, Ph.D., to Chief Drug Development Officer.

Orthofix Announces First US Pediatric Implant of the Fitbone Limb-Lengthening System

Bellicum Pharmaceuticals, Inc . and The University of Texas MD Anderson Cancer Center today announced a global option and license agreement covering certain intellectual property and technology rights regarding Bellicum’s CaspaCIDe®